Catalyst Pharmaceuticals Inc (STU:CN2)
€ 21.4 -1.81 (-7.8%) Market Cap: 2.54 Bil Enterprise Value: 2.11 Bil PE Ratio: 18.58 PB Ratio: 3.96 GF Score: 83/100

Catalyst Pharmaceuticals Inc (STU:CN2) Transcripts

  • 1